PerkinElmer Aktie

95,60USD -2,68USD -2,73%
PerkinElmer für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 850943 / ISIN: US7140461093

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
<
Aktion
Portfolio
Watchlist
>

Personal

2021 2022 2023 2024 2025
Personal am Ende des Jahres 16 700 16 700 11 500 11 000 11 000
Umsatz pro Mitarbeiter in Mio. EUR 0,30 0,20 0,24 0,25 0,26

Bilanz (in Mio. USD) - Aktiva

2021 2022 2023 2024 2025
Summe Umlaufvermögen 2 441 3 289 3 001 2 350 2 240
Summe Anlagevermögen 12 560 10 841 10 564 10 043 9 929
Summe Aktiva 15 001 14 130 13 565 12 392 12 168

Bilanz (in Mio. USD) - Passiva

2021 2022 2023 2024 2025
Summe Fremdkapital 7 859 6 747 5 692 4 726 4 918
Summe Eigenkapital 7 141 7 383 7 873 7 667 7 250
Summe Passiva 15 001 14 130 13 565 12 392 12 168

Adresse

77 Citypoint 4th Avenue, 02451 Waltham
Telefon +1 (781) 663-6900
Internet http://www.revvity.com

Management

Alexis Platon Michas
Independent Non-Executive Chairman
Anita Gonzales
Chief Accounting Officer & Vice President
Arvind Sundar Rajan
Senior VP, Chief Digital & Strategy Officer
Bryan A. Kipp
Senior Vice President-Technology & Licensing
Franklin R. Witney
Independent Director
Jayashree Kailas Thacker
Chief Automation Officer & Senior Vice President
Joel S. Goldberg
Secretary, SVP-Administration & General Counsel
Madhuri Hegde
Chief Scientific Officer & Senior Vice President
Magali Four
Chief People & Culture Officer & SVP
Maxwell Krakowiak
Chief Financial Officer & Senior Vice President
Michael A. Klobuchar
Independent Director
Michel Pericles Vounatsos
Independent Director
Michelle McMurry-Heath
Independent Director
Miriame Victor
Chief Commercial Officer & Senior Vice President
Pascale Witz
Independent Non-Executive Director
Peter Barrett
Independent Director
Prahlad Ramadhar Singh
President, Chief Executive Officer & Director
Samuel Ross Chapin
Independent Director
Sophie V. Vandebroek
Independent Director
Steve Willoughby
Vice President-Investor Relations
Tajinder S. Vohra
Senior Vice President-Global Operations
Yi Ping Lin
Chief Quality, Regulatory & Clinical Officer